Muhlis Akman (M Akman)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Low Density Lipoprotein

Gene Expression

Top Venues

Cell death & disease

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

C Ariano, F Costanza, Muhlis Akman, Chiara Riganti, D Corà, Elena Casanova, E Astanina, V Comunanza, Federico Bussolino, Gabriella Doronzo
TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism. Cell death & disease 14 (5) (2023)
C Ariano, F Costanza, Muhlis Akman, Chiara Riganti, D Corà, Elena Casanova, E Astanina, V Comunanza, Federico Bussolino, Gabriella Doronzo
TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism. Cell death & disease 14 (5) (2023)
C Ariano, F Costanza, Muhlis Akman, Chiara Riganti, D Corà, Elena Casanova, E Astanina, V Comunanza, Federico Bussolino, Gabriella Doronzo
TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism. Cell death & disease 14 (5) (2023)
C Ariano, F Costanza, Muhlis Akman, Chiara Riganti, D Corà, Elena Casanova, E Astanina, V Comunanza, Federico Bussolino, Gabriella Doronzo
TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism. Cell death & disease 14 (5) (2023)
Dario P Anobile, Iris Chiara Salaroglio, Fabrizio Tabbò, Sofia La Vecchia, Muhlis Akman, Francesca Napoli, Maristella Bungaro, Federica Benso, Elisabetta Aldieri, Paolo Bironzo, Joanna Kopecka, Francesco Passiglia, Luisella Righi, Silvia Novello, Giorgio Vittorio Scagliotti, Chiara Riganti
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)